New cancer drug enters first human trials
NCT ID NCT06764771
Summary
This early-stage study is testing an experimental drug called BMS-986488, both alone and in combination with other therapies, in people with advanced cancers that have spread or cannot be removed by surgery. The main goals are to check if the treatment is safe and tolerable, and to see if it shows any signs of fighting the cancer. The study is enrolling 437 adults with specific advanced solid tumors including kidney, lung, colorectal, pancreatic, and ovarian cancers.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED MALIGNANT TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Local Institution - 0015
Montreal, Quebec, H2X 0A9, Canada
-
Local Institution - 0016
Québec, Quebec, G1J 1Z4, Canada
-
Local Institution - 0020
Allentown, Pennsylvania, 18103, United States
-
Local Institution - 0021
Hackensack, New Jersey, 07601, United States
-
Local Institution - 0024
Germantown, Tennessee, 38138, United States
-
Local Institution - 0031
Brisbane, Queensland, 4029, Australia
-
Local Institution - 0032
Vancouver, British Columbia, V5Z 4E6, Canada
Conditions
Explore the condition pages connected to this study.